Dube Eric M

Company

Date

Role

Action

Shares

Amount

Of holding

TVTX Travere Therapeutics, Inc.

17 Sep 2026

CHIEF EXECUTIVE OFFICER

Sold on a plan

108,493

$7.01M

20.0%

TVTX Travere Therapeutics, Inc.

16 Sep 2026

CHIEF EXECUTIVE OFFICER

Sold on a plan

195,841

$12.43M

31.1%

TVTX Travere Therapeutics, Inc.

15 Sep 2026

CHIEF EXECUTIVE OFFICER

Sold on a plan

95,666

$5.96M

18.1%

TVTX Travere Therapeutics, Inc.

6 May 2026

CHIEF EXECUTIVE OFFICER

Sold on a plan

22,500

$988.88K

4.9%

TVTX Travere Therapeutics, Inc.

15 Apr 2026

CHIEF EXECUTIVE OFFICER

Sold on a plan

64,000

$2.63M

12.9%

TVTX Travere Therapeutics, Inc.

1 Apr 2026

CHIEF EXECUTIVE OFFICER

Sold on a plan

60,000

$1.86M

12.2%

TVTX Travere Therapeutics, Inc.

20 Feb 2026

CHIEF EXECUTIVE OFFICER

Sold on a plan

60,000

$1.81M

12.2%

TVTX Travere Therapeutics, Inc.

3 Feb 2026

CHIEF EXECUTIVE OFFICER

Sold on a plan

100,087

$3.23M

18.8%

TVTX Travere Therapeutics, Inc.

27 Jan 2026

CHIEF EXECUTIVE OFFICER

Sold on a plan

51,865

$1.56M

11.0%

TVTX Travere Therapeutics, Inc.

23 Jan 2026

CHIEF EXECUTIVE OFFICER

Sold on a plan

8,135

$244.15K

1.9%

TVTX Travere Therapeutics, Inc.

29 Oct 2025

CHIEF EXECUTIVE OFFICER

Sold on a plan

27,128

$817.07K

6.1%

TVTX Travere Therapeutics, Inc.

28 Oct 2025

CHIEF EXECUTIVE OFFICER

Sold on a plan

92,872

$2.82M

18.1%

TVTX Travere Therapeutics, Inc.

5 May 2025

CHIEF EXECUTIVE OFFICER

Sold on a plan

18,924

$398.35K

4.3%

TVTX Travere Therapeutics, Inc.

11 Feb 2025

CHIEF EXECUTIVE OFFICER

Sold on a plan

11,375

$273.46K

2.6%

TVTX Travere Therapeutics, Inc.

3 Feb 2025

CHIEF EXECUTIVE OFFICER

Sold on a plan

50,691

$1.02M

10.5%

TVTX Travere Therapeutics, Inc.

22 Jan 2025

CHIEF EXECUTIVE OFFICER

Sold on a plan

10,736

$208.92K

3.0%

TVTX Travere Therapeutics, Inc.

9 Sep 2024

CHIEF EXECUTIVE OFFICER

Sold on a plan

21,125

$243.36K

5.5%

TVTX Travere Therapeutics, Inc.

1 Feb 2024

CHIEF EXECUTIVE OFFICER

Sold at will

19,122

$166.44K

5.2%

TVTX Travere Therapeutics, Inc.

23 Jan 2024

CHIEF EXECUTIVE OFFICER

Sold at will

7,873

$70.54K

3.2%

TVTX Travere Therapeutics, Inc.

5 Sep 2023

Chief Executive Officer

Sold at will

4,455

$65.53K

1.8%

TVTX Travere Therapeutics, Inc.

1 Feb 2023

Chief Executive Officer

Sold, plan not stated

8,196

$182.36K

3.3%

TVTX Travere Therapeutics, Inc.

24 Jan 2023

Chief Executive Officer

Sold, plan not stated

6,442

$138.50K

4.2%

TVTX Travere Therapeutics, Inc.

5 Jan 2023

Chief Executive Officer

Sold, plan not stated

5,625

$116.72K

3.5%

TVTX Travere Therapeutics, Inc.

10 Feb 2022

Chief Executive Officer

Sold, plan not stated

4,832

$134.52K

2.9%

TVTX Travere Therapeutics, Inc.

31 Jan 2022

Chief Executive Officer

Sold, plan not stated

4,813

$131.88K

2.8%

TVTX Travere Therapeutics, Inc.

24 Jan 2022

Chief Executive Officer

Sold, plan not stated

7,873

$196.67K

5.6%

TVTX Travere Therapeutics, Inc.

5 Jan 2022

Chief Executive Officer

Sold, plan not stated

12,500

$374.37K

8.2%

TVTX Travere Therapeutics, Inc.

4 Jan 2022

Chief Executive Officer

Sold, plan not stated

4,832

$147.04K

3.1%

TVTX Travere Therapeutics, Inc.

17 Aug 2021

Chief Executive Officer

Sold, plan not stated

7,836

$134.14K

4.8%

TVTX Travere Therapeutics, Inc.

2 Jun 2021

Chief Executive Officer

Sold, plan not stated

4,780

$68.59K

3.1%

TVTX Travere Therapeutics, Inc.

1 Jun 2021

Chief Executive Officer

Sold, plan not stated

4,782

$71.20K

3.0%

TVTX Travere Therapeutics, Inc.

8 Feb 2021

Chief Executive Officer

Sold, plan not stated

4,813

$151.99K

3.0%

TVTX Travere Therapeutics, Inc.

5 Feb 2021

Chief Executive Officer

Sold, plan not stated

4,813

$151.18K

2.9%

TVTX Travere Therapeutics, Inc.

3 Feb 2021

Chief Executive Officer

Sold, plan not stated

2,406

$69.56K

1.6%

TVTX Travere Therapeutics, Inc.

2 Feb 2021

Chief Executive Officer

Sold, plan not stated

8,734

$261.27K

5.5%

TVTX Travere Therapeutics, Inc.

6 Jan 2021

Chief Executive Officer

Sold, plan not stated

3,438

$92.86K

3.8%

TVTX Travere Therapeutics, Inc.

5 Jan 2021

Chief Executive Officer

Sold, plan not stated

3,438

$91.62K

3.6%

TVTX Travere Therapeutics, Inc.

21 Sep 2020

Chief Executive Officer

Sold, plan not stated

10,805

$208.32K

10.2%

TVTX Travere Therapeutics, Inc.

8 Jan 2020

Chief Executive Officer

Sold, plan not stated

3,750

$56.78K

8.1%

TVTX Travere Therapeutics, Inc.

7 Jan 2020

Chief Executive Officer

Sold, plan not stated

3,750

$52.28K

7.5%